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Intraoperative evaluation of sentinel lymph nodes has become routine in many units that manage early
breast carcinoma. The procedure is associated with minimal morbidity and can be cost effective, avoiding
re operation and reducing hospital stay as an axillary clearance can be performed under the same
anesthetic after a positive intraoperative diagnosis without awaiting conventional parafﬁn histology. In
negative cases extensive axillary lymph node dissection and its associated side effects can be avoided
altogether. With careful patient selection, the expertise of surgeons and pathologists can increase the
sensitivity and speciﬁcity of the technique with a reduction in false negatives. A number of international
studies have established the usefulness of intraoperative sentinel lymph node evaluation. However, no
local study has assessed the accuracy of frozen section in evaluating sentinel lymph node biopsy. The
purpose of our study was to compare the two techniques (frozen section versus conventional parafﬁn
histology) of the sentinel lymph node examination and to present our local data highlighting its
usefulness and pitfalls, comparing the results with those in published studies. From the results obtained,
we strongly recommend intraoperative assessment of the sentinel lymph nodes in breast carcinoma
patients; frozen section microscopy can be a reliable and accurate technique in the hands of an expe-
rienced histopathologist.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Breast carcinoma is the second leading cause of cancere related
deaths among women worldwide1 and the presence of axillary
lymph node metastases has been regarded as a predictor of poorer
survival.2 Traditionally, axillary lymph node status has been
determined by axillary lymph node dissection (ALND) which
carries a recognized morbidity including the risk of paresthesiae or
pain, hematoma, seroma, restricted shoulder movement and lym-
phedema. The only patients who can derive beneﬁt from axillary
lymph node dissection are those with positive nodes, accounting
for 40% or fewer of all patients who undergo ALND.3e5 If the sen-
tinel node is free of tumor on frozen section, ALND and its asso-
ciated morbidity can be avoided unless a metastasis or
micrometastasis is evident on subsequent parafﬁn histology. Thirty
two published studies6 of the sentinel lymph node biopsy with
back up axillary dissection have indicated that the sentinel lymph
node can detect axillary metastases in 93% of node positive(A. Moatasim), dr.shafaq@
(N. Faridi).
ciates Ltd. Published by Elsevier Ltpatients, so many hospitals now offer intraoperative evaluation of
sentinel lymph node (SLN) biopsy with no further axillary surgery
needed in node negative cases.
Having said this, frozen section assessment of the sentinel
lymph nodes has been considered as time consuming, costly and
subject to false negative results, with a reported sensitivity varying
from 60 to 75%.7e10 We report the experience of one breast unit
with this technique and discuss the beneﬁts and pitfalls. Intra-
operative sentinel lymph node evaluation is being performed in
limited centres in Pakistan, restricted by cost and limited experi-
ence amongst surgeons and histopathologists not comfortable and/
or adequately trained in this technique. Liaquat National Hospital
Karachi is one of the few hospitals in Pakistanwhere this technique
is routinely performed for managing breast carcinoma patients. In
this study we have compared the two techniques, intraoperative
frozen section and permanent parafﬁn sections, for evaluating
sentinel lymph nodes in breast carcinoma patients.
2. Materials and methods
This observational study was conducted from 2005 to 2010, in the Histopa-
thology Department at Liaquat National Hospital, Karachi in collaboration with the
Surgical Unit. All cases of breast carcinoma having clinically negative axillary lymphd. All rights reserved.
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nodes. Neoadjuvant therapy was given to patients in whom the tumor was large,
adherent to skeletal muscle or surgically unresectable. The neoadjuvant therapy
consisted of adriamycin and cyclophosphamide for the ﬁrst three months and
docetaxel for the last three months with or without herceptin depending on Her-2-
neu status. Cases with ALN involvement, proven either on histology or cytology prior
to the main surgery were excluded from the study. Preoperative ultrasound
assessment of axillary lymph nodes was not carried out in any of the cases.
All breast tumors were preoperatively proven as positive for carcinoma on ﬁne
needle aspiration cytology (followed by conﬁrmation on frozen section preceding
any radical surgery) or incisional biopsy. Consent for surgery was taken by the
department of surgery.
The selected cases underwent lymphoscintigraphic mapping approximately 6 h
prior to surgery. Technetium 99 labelled isotope was injected subepidermally in the
peritumoral area in a dose of 37 mbq/4 injections of 9.2 mbq (volume ¼ 1 ml/4
injections of 0.25 ml). Sentinel lymph node biopsy was performed before removal of
the primary tumor. The intraoperative frozen section assessment of the sentinel
lymph node(s) was performed in the histopathology department with subsequent
conﬁrmation on parafﬁn sections. An operating room (OR) nurse accompanied the
sentinel node specimen along with a request form. The histopathology staff used
protective gloves, masks and disposable aprons while handling radioactive tissue.
The time of receipt of lymph node(s) was recorded on the request form.
After initial measurements and recording of the number of lymph nodes
received, excess fat from each node was trimmed off. A small lymph node (¼ or
<1 cm) was bisected and entirely submitted in one cassette. Lymph nodes >1 cm
were serially sliced at 2 mm intervals perpendicular to the long axis and submitted
entirely (not more than two slices in one cassette) to decrease the number of false
negatives. A large lymph node was submitted in multiple cassettes. The specimen
was then immediately frozen and thin sections were cut on a cryostat machine
(Fig. 1). Sections were stained with Hematoxylin & Eosin. If on microscopy the ﬁrst
level of a lymph nodewas negative, a minimum of 3 additional levels of each section
were examined. Any ambiguous section showing freezing and cutting artifacts was
rejected and a new section was requested. A negative diagnosis was only given after
all levels of submitted sections were examined carefully. In the case of a positive
node an attempt was made to classify it as a micro or macrometastasis (the latter
deﬁned as a tumor deposit of more than 2 mm in size, a micrometastasis as a tumor
deposit of 0.2e2 mm in size, and isolated tumor cells as single or clusters of tumor
cells of less than 0.2 mm in aggregate size).
Once a node was found to be positive, the examination of other lymph nodes
being processed was halted. A positive or negative result was promptly communi-
cated by telephone by the histopathologist to the operating surgeon who modiﬁed
the surgery accordingly. This intraoperative assessment was undertaken by a single
consultant histopathologist in rotation. In doubtful cases (of micrometastasis or
single tumor cells especially) a second opinion by another colleague was sought. TheFig. 1. Serial slicing and processing of a setissue was then processed routinely and parafﬁn sections were examined to conﬁrm
the frozen section diagnosis. Where there was a discrepancy between the results of
frozen and parafﬁn sections, the frozen section slides were re examined preferably
by the primary reporting pathologist and re-checked by another consultant histo-
pathologist. Immunohistochemistry, using CKAE1/AE3, was also available (Fig. 2).
Before the ﬁnal report was issued, the operating surgeonwas informed of the change
in status.
In each case, patient and tumor demography were recorded. Statistical analysis
was done by calculating sensitivity, speciﬁcity, accuracy, and positive and negative
predictive values.3. Results
From 2005 to 2010, 100 patients meeting the selection criteria
underwent intraoperative assessment of sentinel lymph nodes. All
patients were female. The mean age of the patients was 49.81 years
with a standard deviation of 11.1 and median of 50 years. As the
OR was on the same ﬂoor as the histopathology department,
minimal time was wasted on sample transportation (<5 min). The
operating surgeon while awaiting the sentinel biopsy report per-
formed either a modiﬁed radical mastectomy or a breast conser-
vation type complete local excision. The ﬁnal specimens received in
100 cases were 67 mastectomies and 33 complete local excisions
with cavity shavings sent separately. 7/100 surgeries followed post
neoadjuvant therapy, with no residual tumor found after thorough
sampling. In none of these had a hook wire been inserted preop-
eratively (Table 1).
A total of 200 sentinel nodes were examined by frozen section,
with a mean of 2 nodes per case. The number of nodes sent for
intraoperative evaluation ranged from 1 to 6 (Table 2). The size of
lymph nodes ranged from 0.5 to 3 cm in maximum dimensionwith
a median of 2 cm and mean of 1.8 cm (0.67 SD). In 32 cases
a positive diagnosis on frozen section was given (total nodes pos-
itive n ¼ 45). Where an axillary dissection specimen was available
(84/100), an attempt was made to assess the ﬁnal nodal status in
cases reported negative on frozen section: no further metastasis
was detected in any of these. However, in 4 additional cases,ntinel lymph node for frozen section.
Table 2
Frequency of nodes received.
Number of nodes received 01 02 03 04 05 06 Total
Number of cases 32 46 11 3 5 1 100
Total number of examined
nodes
32 92 33 12 25 06 200
Fig. 2. Subcapsular micrometastasis, conﬁrmed on immunohistochemistry using
cytokeratin AE1/AE3 (H&EX10M). Inset showing inﬁltrating ductal carcinoma Grade 2
as seen on parafﬁn section of breast lump of same patient.
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nodes reported negative on frozen section (Table 5). In 03/04 false
negative cases, the complete nodal capsule was not properly
visualized even on multiple levels and micrometastases were
thereforemissed. In 01/04 case, due to inﬁltration of lymph node by
adipose tissue causing improper cutting, a focus of metastatic tu-
mor was missed on frozen section. Immunohistochemistry using
CKAE1/AE3 was performed on parafﬁn section to conﬁrm the
diagnosis in one case as there was a disagreement between two
histopathologists (Fig. 2). The size of nodal (sentinel) metastases
ranged from 1 to 20 mm with a mean of 7 mm.
No false positive case was seen in this study. Primary tumor size
is known to be an important predictor of nodal metastasis, so an
attempt was made to correlate the tumor size with the presence of
metastasis. The tumor size ranged from 1.2 to 6.5 cmwith a median
of 2.6 and mean of 2.7 cm (1.3 SD). The primary tumor size in
sentinel nodes harboring macrometastases ranged from 1.8 to
6.5 cm with a mean of 3.48 and median of 3.35 cm whereas in
nodes with micrometastases, the tumor size ranged from 2.3 to
2.8 cm with mean and median of 2.52 and 2.5 cm respectively.
Table 3 compares tumor size with frequency of micro and macro-
metastases in the sentinel nodes.Table 1
Patient and tumor demography.
Age range (years) 28e78
Mean age (years) 49.81 (Standard deviation  11.1)
Median age (years) 50
Mean tumor size (cm) 2.7 (Standard deviation  1.3)
Axillary sampling (number of cases) 84/100
Histologic diagnosis Frequency Percentage (%)
Inﬁltrating ductal carcinoma 75 75.0
Inﬁltrating lobular carcinoma 2 2.0
Ductal carcinoma in situ (DCIS) 3 3.0
DCIS with microinvasion 3 3.0
Inﬁltrating papillary carcinoma 2 2.0
Inﬁltrating tubular/cribriform
carcinoma
3 3.0
Metaplastic carcinoma 2 2.0
No residual tumor (status post
neoadjuvant therapy)
7 7.0
Solid papillary carcinoma 2 2.0
Mixed (ductal and lobular) 1 1.0
Total 100 100.0The mean time taken to report sentinel node biopsy was
28.15 min with a median of 30 min (range 15e50 min) which ﬁts
well with the average time taken to perform a surgery i.e. 45e
50 min. The increase in reporting time was directly related to the
number of nodes received, especially in negative cases in which at
least three levels were examined. The results of SLN biopsy were
communicated directly via telephone by the histopathologist to the
operating surgeon or her assistant, with no subsequent evidence of
any miscommunication of frozen section reports. The sensitivity,
speciﬁcity, accuracy, and positive and negative predictive values
based on number of patients and number of nodes can be seen in
Table 4.
4. Discussion
The technique of sentinel lymph node assessment was ﬁrst
introduced by Giuliano11 and has recently become a standard
procedure in centres dealing with a large number of breast carci-
noma patients. According to the recommendations of the Ameri-
can Society of Oncology12 SLN biopsy is an appropriate alternative
to routine staging axillary lymph node dissection (ALND) for pa-
tients with early stage breast cancer having clinically negative
axillary nodes. Complete axillary lymph node dissection remains
standard treatment for patients with axillary metastases identiﬁed
on the SLN biopsy. In experienced hands, properly identiﬁed pa-
tients with a negative result on SLN biopsy are not likely to require
complete ALND.
SLN biopsy is associated with less morbidity than ALND,13 but
the relative effects of these two approaches on tumor recurrence or
patient survival are unknown. Like surgeons, pathologists evalu-
ating the SLN specimens should be experienced, and should also
conform to uniform reporting criteria. The greatest challenge lies in
assessing minimal disease in extensive SLN evaluation. The success
of the procedure is largely dependent on a multidisciplinary co-
operation amongst surgeons, pathologists and nuclear medicine
specialists.14 Like any technique, frozen section has its own disad-
vantages including cost, labor, requirement of a skilled histopa-
thology technician and a dedicated histopathologist for each
surgical procedure. In a busy centre where multiple patients un-
dergo operation in a single day, the burden on the histopathology
staff and department can be immense.
As a technique, frozen section is morphologically inferior to
parafﬁn section histology (Fig. 3) and may miss subtle lymph node
metastases (Fig. 4). Similarly, identiﬁcation of the sentinel lymph
node preoperatively using a blue dye or a radioactive isotope is
associated with a number of problems ranging from logisticale likeTable 3
Comparison of primary tumor size with proportion of sentinel nodal metastasis.
Tumor size
(cm) n ¼ 100
Proportion of
micrometastases
in sentinel nodes (%)
Proportion of macrometastases
in sentinel nodes (%)
No residual tumor
n ¼ 7
0 0
2 cm(T1) n ¼ 29 3.4% (n ¼ 1) 3.4% (n ¼ 1)
>2 cm but 5 cm
(T2) n ¼ 61
16.4% (n ¼ 10) 34.4% (n ¼ 21)
>5 cm (T3) n ¼ 3 0 100% (n ¼ 3)
Fig. 3. A large focus of metastatic carcinoma (arrow). Effacement of nodal architecture
on the left by cords and sheets of tumor cells having pleomorphic, hyperchromatic
nuclei (H&EX10M). Inset showing inﬁltrating ductal carcinoma Grade 2 on parafﬁn
section of breast lump of same patient..
Table 4
Results of frozen section evaluation of SLN biopsy.
Based on number
of patients
Based on number
of nodes
False positive 0 0
False negative 11% 8%
Sensitivity (TP/TP þ FN) 90% 92.4%
Speciﬁcity (TN/TN þ FP) 100% 100%
Accuracy (TP þ TN/TP þ TN
þ FP þ FN)
96% 98%
Positive predictive value
(TP/TP þ FP)
100% 100%
Negative predictive value
(TN/TN þ FN)
94.1% 97.4%
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anaphylaxis caused by blue dye, not to mention failure to recognize
the sentinel nodes by both techniques. A recent article has advo-
cated the use of contrast enhanced ultrasound for correct pre-
operative identiﬁcation of the sentinel lymph node,15biopsy of
which if positive can lead to ALND without the need for intra-
operative studies. According to Weiser et al.6 the sensitivity of
intraoperative frozen section is dependent on tumor size and false
negative results are largely due to failure to detect micro-
metastases, a problem which can sometimes be addressed by
performing rapid immunohistochemistry (IHC). A combination of
touch imprint with either frozen section or rapid immunohis-
tochemistry or the combination of all the threemethods can help to
improve the intraoperative diagnosis and allow detection of
micrometastases.16 Leikola and Weinberg17,18 have recommended
the use of intraoperative IHC to improve the intraoperative diag-
nosis of the SLN metastases. Although, IHC can be helpful in
detecting micrometastases, its routine use in SLN assessment is
controversial in terms of cost effectiveness and increased workload
on the laboratory services. We did not perform immunohis-
tochemistry intraoperatively in our study due to cost constraint. Its
use was limited to one case on parafﬁn sections.
In our study, the sensitivity, speciﬁcity, accuracy, and positive
and negative predictive values of intraoperative sentinel lymph
node assessment were 90%, 100% and 96%, 100% and 94.1%
respectively based on number of patients. There was no false pos-
itive case in our study but the rate of false negative was 11%
(Table 4). The 03/04 false negative cases on frozen section were
those that harboredmicrometastasesmissed because of thick nodal
capsules not cut sufﬁciently ﬁnely. In 01/04 false negative case,
a metastatic deposit was missed due to fat inﬁltration of lymph
node that interfered with adequate cutting on frozen section. Un-
derstandably, serial slicing of lymph nodes, examining multiple
levels and proven expertise of the histopathologist can improve the
frozen section diagnosis. Another source of potential error not seen
in our series is a lobular histology where cells are bland and have an
inﬁltrative pattern. The reported sensitivity and false negative re-
sults of frozen section assessment of SLN biopsy by Veronesi et al.19
were 64% and 24% respectively. Their high false negatives were due
to micrometastases. Krag et al.20 reported sensitivity, accuracy and
negative predictive values of 88.6%, 96.8% and 95.7% respectively. In
an eight year institutional study21 on breast carcinoma patients
undergoing intraoperative frozen section analysis of the SLN bi-
opsy, the false-negative rate was 26.6%, the false-positive rate wasTable 5
Comparison of diagnosis on frozen section vs permanent parafﬁn sections.
Total no of sentinel
lymph nodes removed
Total sentinel nodes
positive on frozen section
Total sentinel nodes
positive on parafﬁn sections
200 45 490%, and the overall accuracy was 94%. Our study has shown sig-
niﬁcantly improved results due to meticulous sampling and
examining multiple levels during frozen section. As in Veronesi’s
series,19 the false negatives were all due to micrometastases and
these patients were not offered further surgery, as per the protocol
of the surgical unit.
The size of a metastatic deposit is an important predictor of
possible additional axillary metastases and can assist in person-
alizing surgical management of breast cancer.22 In our study the
size of nodal (sentinel) metastases ranged from 1 to 20 mm with
a mean of 7 mm.
The mean age of patients in our study was 49.81  11.1years,
considerably younger than in Western countries.
The mean tumor size in our study was 2.7 cm  1.3, ranging
from 1.2 to 6.5 cm. The larger tumor sizewas due tomultiple factors
including late referral to a specialized breast centre due to lack of
awareness, social pressures, limited ﬁnancial resources, reluctance
to be examined by male surgeons and shortage of female breast
surgeons. The outcome can only be improved through a deﬁnite
commitment by policy makers and health ofﬁcials. Awareness
campaigns are available but the efforts need to be exhaustive and
a national drive for breast cancer screening is needed. These are
only a few suggestions that can improve the outlook of breast
carcinoma in our region.
In future, automated molecular tests including quantitative
reverse transcriptase-polymerase chain reaction (qRT-PCR) and one
step nucleic acid ampliﬁcation (OSNA) using mammoglobin (MGB)
1 and cytokeratin (CK) 19 can be utilized for detectingmetastases in
sentinel lymph nodes. Various papers have been published evalu-
ating their application, many with promising results23e27 with an
overall sensitivity exceeding that of histopathological examination.
These techniques also appear to detect lobular histology more
effectively and can differentiate macro from micrometastases.
These tests could be incorporated during frozen section evaluation
of sentinel lymph nodes.
Another future possible technique is elastic scattering
spectroscopy (ESS) that detects the abnormal cellular architecture
present in metastatic disease through changes in light absorption
and scattering. ESS offers the possibility of intraoperative
analysis of the sentinel node without the need for a specialist
pathologist, and has other potential advantages such as minimal
Fig. 4. Micrometastasis (arrows) in a sentinel lymph node. (a) A suspicious focus seen on frozen section (H&EX4M), (b) On high power (H&EX20M) cords and groups of tumor cells
seen in subcapsular area.
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running costs.
Intraoperative analysis of the SLN biopsy continues to evolve,
and is becoming more widespread. The question remains as to
which technique will dominate future practice? Apart from con-
ventional histology, intraoperative molecular-based techniques
offer a greater ability to detect low-volumemetastatic disease. They
can provide quick results, are cost effective and do not invoke the
expense of a dedicated pathologist.28 As the debate continues, we
should try to incorporate reliable, cost-effective techniques suited
to our facilities and budget.5. Conclusion
We recommend routine frozen section evaluation of SLN biopsy
in early breast carcinoma patients as it is a reliable and accurate
technique allowing immediate assessment of axillary lymph node
status at the time of surgery. However, it requires experience and is
associated with pitfalls including failure to detect micrometastases.
In skilled hands, the technique is almost comparable to routine
histology and its advantages, including minimal morbidity and the
avoidance of re operation with its associated costs; appear to out-
weigh its perceived drawbacks.Ethical approval
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